|
US4196265A
(en)
|
1977-06-15 |
1980-04-01 |
The Wistar Institute |
Method of producing antibodies
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4172124A
(en)
|
1978-04-28 |
1979-10-23 |
The Wistar Institute |
Method of producing tumor antibodies
|
|
US4608337A
(en)
|
1980-11-07 |
1986-08-26 |
The Wistar Institute |
Human hybridomas and the production of human monoclonal antibodies by human hybridomas
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4701409A
(en)
|
1984-11-15 |
1987-10-20 |
The Wistar Institute |
Detection of B-cell neoplasms
|
|
US4693975A
(en)
|
1984-11-20 |
1987-09-15 |
The Wistar Institute |
Human hybridroma fusion partner for production of human monoclonal antibodies
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5015568A
(en)
|
1986-07-09 |
1991-05-14 |
The Wistar Institute |
Diagnostic methods for detecting lymphomas in humans
|
|
US5202429A
(en)
|
1986-07-09 |
1993-04-13 |
The Wistar Institute |
DNA molecules having human BCL-2 gene sequences
|
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
ATE120497T1
(de)
|
1988-05-09 |
1995-04-15 |
Univ Temple |
Verfahren zur voraussage der wirksamkeit einer antineoplastichen behandlung bei einzelnen patienten.
|
|
US5198338A
(en)
|
1989-05-31 |
1993-03-30 |
Temple University |
Molecular probing for human t-cell leukemia and lymphoma
|
|
US5149628A
(en)
|
1989-11-15 |
1992-09-22 |
Temple University |
Methods for detecting bcl-3 gene in human leukemias
|
|
US5061620A
(en)
|
1990-03-30 |
1991-10-29 |
Systemix, Inc. |
Human hematopoietic stem cell
|
|
US5635387A
(en)
|
1990-04-23 |
1997-06-03 |
Cellpro, Inc. |
Methods and device for culturing human hematopoietic cells and their precursors
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
WO1993012136A1
(en)
|
1991-12-11 |
1993-06-24 |
Thomas Jefferson University |
Detection and treatment of acute leukemias resulting from chromosome abnormalities in the all-1 region
|
|
US5633135A
(en)
|
1991-12-11 |
1997-05-27 |
Thomas Jefferson University |
Chimeric nucleic acids and proteins resulting from ALL-1 region chromosome abnormalities
|
|
US6040140A
(en)
|
1991-12-11 |
2000-03-21 |
Thomas Jefferson University |
Methods for screening and treating leukemias resulting from all-1 region chromosome abnormalities
|
|
US5587308A
(en)
|
1992-06-02 |
1996-12-24 |
The United States Of America As Represented By The Department Of Health & Human Services |
Modified adeno-associated virus vector capable of expression from a novel promoter
|
|
US5674682A
(en)
|
1992-10-29 |
1997-10-07 |
Thomas Jefferson University |
Nucleic acid primers for detecting micrometastasis of prostate cancer
|
|
WO1994010343A1
(en)
|
1992-10-29 |
1994-05-11 |
Thomas Jefferson University |
Methods of detecting micrometastasis of prostate cancer
|
|
US5478745A
(en)
|
1992-12-04 |
1995-12-26 |
University Of Pittsburgh |
Recombinant viral vector system
|
|
US5985598A
(en)
|
1994-10-27 |
1999-11-16 |
Thomas Jefferson University |
TCL-1 gene and protein and related methods and compositions
|
|
US7175995B1
(en)
|
1994-10-27 |
2007-02-13 |
Thomas Jefferson University |
TCL-1 protein and related methods
|
|
US5789389A
(en)
|
1995-03-17 |
1998-08-04 |
Board Of Trustees Of University Of Illinois |
BCL2 derived genetic elements associated with sensitivity to chemotherapeutic drugs
|
|
US5695944A
(en)
|
1995-05-05 |
1997-12-09 |
Thomas Jefferson University |
Modulation of bcl-2 phosphorylation
|
|
US5567586A
(en)
|
1995-05-18 |
1996-10-22 |
Thomas Jefferson University |
Methods of indentifying solid tumors with chromosome abnormalities in the ALL-1 region
|
|
US5928884A
(en)
|
1996-02-09 |
1999-07-27 |
Croce; Carlo M. |
FHIT proteins and nucleic acids and methods based thereon
|
|
US6242212B1
(en)
|
1996-02-09 |
2001-06-05 |
Thomas Jefferson University |
Fragile histidine triad (FHIT) nucleic acids and methods of producing FHIT proteins
|
|
WO1998035707A1
(en)
|
1997-02-18 |
1998-08-20 |
Thomas Jefferson University |
Compositions that bind to pancreatic cancer cells and methods of using the same
|
|
EP0972083A1
(en)
|
1997-04-04 |
2000-01-19 |
THE TEXAS A&M UNIVERSITY SYSTEM |
Noninvasive detection of colonic biomarkers using fecal messenger rna
|
|
CA2335315A1
(en)
|
1998-07-20 |
2000-01-27 |
Thomas Jefferson University |
Nitrilase homologs
|
|
WO2000005419A1
(en)
|
1998-07-24 |
2000-02-03 |
Yeda Research And Development Company Ltd. |
Prevention of metastasis with 5-aza-2'-deoxycytidine
|
|
US7141417B1
(en)
|
1999-02-25 |
2006-11-28 |
Thomas Jefferson University |
Compositions, kits, and methods relating to the human FEZ1 gene, a novel tumor suppressor gene
|
|
CA2367906A1
(en)
|
1999-03-15 |
2000-09-21 |
Thomas Jefferson University |
Tcl-1b gene and protein and related methods and compositions
|
|
US7163801B2
(en)
|
1999-09-01 |
2007-01-16 |
The Burnham Institute |
Methods for determining the prognosis for cancer patients using tucan
|
|
US6891031B2
(en)
|
2000-02-18 |
2005-05-10 |
The Regents Of The University Of California |
Coordinate cytokine regulatory sequences
|
|
US20010026796A1
(en)
|
2000-03-14 |
2001-10-04 |
Croce Carlo M. |
TCL1 enhances Akt kinase activity and mediates its nuclear translocation
|
|
EP1309726B2
(en)
|
2000-03-30 |
2018-10-03 |
Whitehead Institute For Biomedical Research |
Rna sequence-specific mediators of rna interference
|
|
EP1276879A4
(en)
|
2000-04-11 |
2004-12-22 |
Univ Jefferson |
MUIR-TORRE-LIKE SYNDROME IN Fhit-DEFECTIVE MICE
|
|
US20020086331A1
(en)
|
2000-05-16 |
2002-07-04 |
Carlo Croce |
Crystal structure of worm NitFhit reveals that a Nit tetramer binds two Fhit dimers
|
|
US7060811B2
(en)
|
2000-10-13 |
2006-06-13 |
Board Of Regents, The University Of Texas System |
WWOX: a tumor suppressor gene mutated in multiple cancers
|
|
HUP0400314A3
(en)
|
2001-03-23 |
2006-02-28 |
Shire Biochem Inc Laval |
Pharmaceutical combinations for the treatment of cancer
|
|
US20040033502A1
(en)
|
2001-03-28 |
2004-02-19 |
Amanda Williams |
Gene expression profiles in esophageal tissue
|
|
US20050176025A1
(en)
*
|
2001-05-18 |
2005-08-11 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of B-cell CLL/Lymphoma-2 (BCL-2) gene expression using short interfering nucleic acid (siNA)
|
|
EP2390328A1
(en)
|
2001-09-28 |
2011-11-30 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
MicroRNA molecules
|
|
US7371736B2
(en)
|
2001-11-07 |
2008-05-13 |
The Board Of Trustees Of The University Of Arkansas |
Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
|
|
GB0128898D0
(en)
|
2001-12-03 |
2002-01-23 |
Biotech Res Ventures Pte Ltd |
Materials and methods relating to the stabilization and activation of a tumour suppressor protein
|
|
AU2003213119A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Sirna Therapeutics, Inc. |
RNA INTERFERENCE MEDIATED INHIBITION OF BCL2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
|
|
ES2555307T3
(es)
|
2002-03-08 |
2015-12-30 |
Eisai R&D Management Co., Ltd. |
Compuestos macrocíclicos útiles como agentes farmacéuticos
|
|
WO2003086445A1
(en)
|
2002-04-08 |
2003-10-23 |
Ciphergen Biosystems, Inc. |
Serum biomarkers in hepatocellular carcinoma
|
|
EP1499182B1
(en)
|
2002-04-29 |
2009-10-28 |
Thomas Jefferson University |
Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression
|
|
EP1530418A4
(en)
|
2002-05-31 |
2005-10-12 |
Univ Leland Stanford Junior |
METHOD FOR IDENTIFYING AND INSULATING STEM CELLS AND CANCER STAMPS
|
|
US20050260639A1
(en)
|
2002-09-30 |
2005-11-24 |
Oncotherapy Science, Inc. |
Method for diagnosing pancreatic cancer
|
|
WO2004033659A2
(en)
|
2002-10-11 |
2004-04-22 |
Thomas Jefferson University |
Novel tumor suppressor gene and compositions and methods for making and using the same
|
|
US20050266443A1
(en)
|
2002-10-11 |
2005-12-01 |
Thomas Jefferson University |
Novel tumor suppressor gene and compositions and methods for making and using the same
|
|
US20040152112A1
(en)
|
2002-11-13 |
2004-08-05 |
Thomas Jefferson University |
Compositions and methods for cancer diagnosis and therapy
|
|
US7250496B2
(en)
|
2002-11-14 |
2007-07-31 |
Rosetta Genomics Ltd. |
Bioinformatically detectable group of novel regulatory genes and uses thereof
|
|
WO2004071464A2
(en)
|
2003-02-12 |
2004-08-26 |
Johns Hopkins University School Of Medicine |
Diagnostic application of differentially-expressed genes in lympho-hematopoietic stem cells
|
|
WO2004079013A1
(en)
|
2003-03-03 |
2004-09-16 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Ecto-5’-nucleotidase (cd73) used in the diagnosis and the treatment of pancreatic cancer
|
|
US7183384B2
(en)
|
2003-03-06 |
2007-02-27 |
A & G Pharmaceutical, Inc. |
Monoclonal antibody 7H11 reactive with human cancer
|
|
AU2003286741A1
(en)
|
2003-05-02 |
2004-11-26 |
Thomas Jefferson University |
Methods and compositions for diagnosis and therapy of parkin-associated disorders
|
|
US20050069918A1
(en)
|
2003-05-29 |
2005-03-31 |
Francois Claret |
JAB1 as a prognostic marker and a therapeutic target for human cancer
|
|
SG179291A1
(en)
|
2003-06-18 |
2012-04-27 |
Genelux Corp |
Modified recombinant vaccinia viruses and other microorganisms, uses thereof
|
|
EP1648914A4
(en)
|
2003-07-31 |
2009-12-16 |
Regulus Therapeutics Inc |
OLIGOMERIC COMPOUNDS AND COMPOSITIONS USEFUL FOR MODULATING SMALL NON-CODING RNA
|
|
US8106180B2
(en)
|
2003-08-07 |
2012-01-31 |
Whitehead Institute For Biomedical Research |
Methods and products for expression of micro RNAs
|
|
US20050037362A1
(en)
|
2003-08-11 |
2005-02-17 |
Eppendorf Array Technologies, S.A. |
Detection and quantification of siRNA on microarrays
|
|
US8412541B2
(en)
|
2003-08-14 |
2013-04-02 |
Edda Technology, Inc. |
Method and system for intelligent qualitative and quantitative analysis for medical diagnosis
|
|
US20050084883A1
(en)
|
2003-08-25 |
2005-04-21 |
The Johns Hopkins University School Of Medicine |
Method of diagnosis and treatment of pancreatic endocrine neoplasms based on differential gene expression analysis
|
|
WO2005031002A2
(en)
|
2003-09-22 |
2005-04-07 |
Rosetta Inpharmatics Llc |
Synthetic lethal screen using rna interference
|
|
JP2007506425A
(ja)
|
2003-09-24 |
2007-03-22 |
オンコセラピー・サイエンス株式会社 |
肝細胞癌を診断する方法
|
|
WO2005047477A2
(en)
|
2003-11-07 |
2005-05-26 |
University Of Massachusetts |
Interspersed repetitive element rnas as substrates, inhibitors and delivery vehicles for rnai
|
|
US20050164252A1
(en)
|
2003-12-04 |
2005-07-28 |
Yeung Wah Hin A. |
Methods using non-genic sequences for the detection, modification and treatment of any disease or improvement of functions of a cell
|
|
DE602004031881D1
(de)
|
2003-12-19 |
2011-04-28 |
Univ California |
Verfahren und materialien zur beurteilung von prostatakrebstherapien
|
|
CA2554818A1
(en)
|
2004-02-09 |
2005-08-25 |
Thomas Jefferson University |
Diagnosis and treatment of cancers with microrna located in or near cancer-associated chromosomal features
|
|
US20050256072A1
(en)
|
2004-02-09 |
2005-11-17 |
University Of Massachusetts |
Dual functional oligonucleotides for use in repressing mutant gene expression
|
|
CA2556435C
(en)
|
2004-02-13 |
2014-08-12 |
The Rockefeller University |
Anti-microrna oligonucleotide molecules
|
|
CA2558366A1
(en)
|
2004-02-23 |
2005-09-01 |
Erasmus Universiteit Rotterdam |
Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling
|
|
US7365058B2
(en)
|
2004-04-13 |
2008-04-29 |
The Rockefeller University |
MicroRNA and methods for inhibiting same
|
|
JP2007533324A
(ja)
|
2004-04-20 |
2007-11-22 |
ゲナコ・バイオメデイカル・プロダクツ・インコーポレイテツド |
ｎｃＲＮＡを検出する方法
|
|
JP5697297B2
(ja)
|
2004-05-14 |
2015-04-08 |
ロゼッタ ジノミクス リミテッド |
マイクロｎａｓおよびその使用
|
|
EP2290071B1
(en)
|
2004-05-28 |
2014-12-31 |
Asuragen, Inc. |
Methods and compositions involving microRNA
|
|
US7635563B2
(en)
|
2004-06-30 |
2009-12-22 |
Massachusetts Institute Of Technology |
High throughput methods relating to microRNA expression analysis
|
|
US20060037088A1
(en)
|
2004-08-13 |
2006-02-16 |
Shulin Li |
Gene expression levels as predictors of chemoradiation response of cancer
|
|
US7893034B2
(en)
|
2004-09-02 |
2011-02-22 |
Yale University |
Regulation of oncogenes by microRNAs
|
|
US7592441B2
(en)
|
2004-10-04 |
2009-09-22 |
Rosetta Genomics Ltd |
Liver cancer-related nucleic acids
|
|
US7642348B2
(en)
|
2004-10-04 |
2010-01-05 |
Rosetta Genomics Ltd |
Prostate cancer-related nucleic acids
|
|
FR2877350B1
(fr)
|
2004-11-03 |
2010-08-27 |
Centre Nat Rech Scient |
IDENTIFICATION ET UTILISATION DE miRNAs IMPLIQUES DANS LA DIFFERENCIATION DE CELLULES ISSUES D'UNE LEUCEMIE MYELOIDE
|
|
EP2314688B1
(en)
*
|
2004-11-12 |
2014-07-16 |
Asuragen, Inc. |
Methods and compositions involving miRNA and miRNA inhibitor molecules
|
|
US7361752B2
(en)
|
2004-12-14 |
2008-04-22 |
Alnylam Pharmaceuticals, Inc. |
RNAi modulation of MLL-AF4 and uses thereof
|
|
US20060185027A1
(en)
|
2004-12-23 |
2006-08-17 |
David Bartel |
Systems and methods for identifying miRNA targets and for altering miRNA and target expression
|
|
US20070099196A1
(en)
|
2004-12-29 |
2007-05-03 |
Sakari Kauppinen |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of micrornas and their target mRNAs
|
|
US8071306B2
(en)
|
2005-01-25 |
2011-12-06 |
Merck Sharp & Dohme Corp. |
Methods for quantitating small RNA molecules
|
|
US20090123912A1
(en)
|
2005-01-25 |
2009-05-14 |
Rosetta Inpharmatics Llc |
Methods for quantitating small RNA molecules
|
|
US20070065840A1
(en)
|
2005-03-23 |
2007-03-22 |
Irena Naguibneva |
Novel oligonucleotide compositions and probe sequences useful for detection and analysis of microRNAS and their target mRNAS
|
|
GB2425311A
(en)
|
2005-04-15 |
2006-10-25 |
Ist Superiore Sanita |
Micro RNA against kit protein
|
|
EP1883709A4
(en)
|
2005-04-29 |
2010-10-13 |
Univ Rockefeller |
HUMAN MICRO-RNAS AND METHOD OF INHIBITING THEM
|
|
EP1904111A4
(en)
|
2005-06-03 |
2009-08-19 |
Univ Johns Hopkins |
COMPOSITIONS AND METHODS FOR REDUCING MICRORNA EXPRESSION FOR THE TREATMENT OF NEOPLASIA
|
|
US20070065844A1
(en)
|
2005-06-08 |
2007-03-22 |
Massachusetts Institute Of Technology |
Solution-based methods for RNA expression profiling
|
|
US20060292616A1
(en)
|
2005-06-23 |
2006-12-28 |
U.S. Genomics, Inc. |
Single molecule miRNA-based disease diagnostic methods
|
|
CN103866018B
(zh)
|
2005-08-01 |
2016-05-25 |
俄亥俄州立大学研究基金会 |
用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
|
|
US20070213292A1
(en)
|
2005-08-10 |
2007-09-13 |
The Rockefeller University |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
|
AU2006279906B2
(en)
|
2005-08-10 |
2012-05-10 |
Alnylam Pharmaceuticals, Inc. |
Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
|
|
CN103028120B
(zh)
|
2005-09-12 |
2015-08-12 |
俄亥俄州立大学研究基金会 |
用于诊断或治疗bcl2相关癌症的组合物和方法
|
|
CN101312740A
(zh)
|
2005-10-05 |
2008-11-26 |
俄亥俄州立大学研究基金会 |
Wwox基因、包含该基因的载体和在癌症治疗中的用途
|
|
US20070092882A1
(en)
|
2005-10-21 |
2007-04-26 |
Hui Wang |
Analysis of microRNA
|
|
US7390792B2
(en)
|
2005-12-15 |
2008-06-24 |
Board Of Regents, The University Of Texas System |
MicroRNA1 therapies
|
|
ES2524018T3
(es)
|
2006-01-05 |
2014-12-03 |
The Ohio State University Research Foundation |
Anomalías de la expresión de microARN en tumores pancreáticos endocrinos y acinares
|
|
WO2007081720A2
(en)
|
2006-01-05 |
2007-07-19 |
The Ohio State University Research Foundation |
Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
|
|
EP2487260B1
(en)
|
2006-01-05 |
2015-07-08 |
The Ohio State University Research Foundation |
Microrna-based methods and compositions for the diagnosis and treatment of solid cancers
|
|
US20090007281A1
(en)
|
2006-01-13 |
2009-01-01 |
Battelle Memorial Institute |
Animal Model for Assessing Copd-Related Diseases
|
|
EP2369012A1
(en)
|
2006-03-20 |
2011-09-28 |
The Ohio State University Research Foundation |
Micro-RNA fingerprints during human megakaryocytopoiesis
|
|
WO2007112097A2
(en)
|
2006-03-24 |
2007-10-04 |
Children's Medical Center Corporation |
Novel signature self renewal gene expression programs
|
|
KR101407707B1
(ko)
|
2006-04-03 |
2014-06-19 |
산타리스 팔마 에이/에스 |
Ａｎｔｉ-ｍｉｒｎａ 안티센스 올리고뉴클레오타이드를 함유하는 약학적 조성물
|
|
AU2007243475B2
(en)
|
2006-04-24 |
2013-02-07 |
The Ohio State University Research Foundation |
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in miR155 transgenic mice
|
|
CA2657030A1
(en)
|
2006-07-13 |
2008-01-17 |
The Ohio State University Research Foundation, An Instrumentality Of The State Of Ohio |
Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
|
|
AU2007297823B2
(en)
|
2006-08-30 |
2012-04-19 |
The Regents Of The University Of Michigan |
New small molecule inhibitors of MDM2 and the uses thereof
|
|
US20080193943A1
(en)
|
2006-09-05 |
2008-08-14 |
Abbott Laboratories |
Companion diagnostic assays for cancer therapy
|
|
US8071292B2
(en)
|
2006-09-19 |
2011-12-06 |
The Ohio State University Research Foundation |
Leukemia diagnostic methods
|
|
JP2010510964A
(ja)
|
2006-09-19 |
2010-04-08 |
アシュラジェン インコーポレイテッド |
治療的介入の標的としての、ｍｉＲ−１５、ｍｉＲ−２６、ｍｉＲ−３１、ｍｉＲ−１４５、ｍｉＲ−１４７、ｍｉＲ−１８８、ｍｉＲ−２１５、ｍｉＲ−２１６、ｍｉＲ−３３１、ｍｍｕ−ｍｉＲ−２９２−３ｐによって調節される遺伝子および経路
|
|
AU2007299828C1
(en)
|
2006-09-19 |
2014-07-17 |
Interpace Diagnostics, Llc |
MicroRNAs differentially expressed in pancreatic diseases and uses thereof
|
|
CA2663878A1
(en)
|
2006-09-19 |
2008-03-27 |
Asuragen, Inc. |
Mir-200 regulated genes and pathways as targets for therapeutic intervention
|
|
JP5501766B2
(ja)
|
2006-11-01 |
2014-05-28 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
肝細胞癌における生存および転移を予測するためのマイクロｒｎａ発現サイン
|
|
US8293684B2
(en)
|
2006-11-29 |
2012-10-23 |
Exiqon |
Locked nucleic acid reagents for labelling nucleic acids
|
|
WO2008070082A2
(en)
|
2006-12-04 |
2008-06-12 |
The Johns Hopkins University |
Stem-progenitor cell specific micro-ribonucleic acids and uses thereof
|
|
AU2007333106A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
miR-20 regulated genes and pathways as targets for therapeutic intervention
|
|
CA2671299A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Functions and targets of let-7 micro rnas
|
|
CN101622350A
(zh)
|
2006-12-08 |
2010-01-06 |
奥斯瑞根公司 |
作为干预治疗靶标的miR-126调控基因和通路
|
|
CA2671294A1
(en)
|
2006-12-08 |
2008-06-19 |
Asuragen, Inc. |
Mir-21 regulated genes and pathways as targets for therapeutic intervention
|
|
US20090175827A1
(en)
|
2006-12-29 |
2009-07-09 |
Byrom Mike W |
miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
|
US8034560B2
(en)
|
2007-01-31 |
2011-10-11 |
The Ohio State University Research Foundation |
MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia (AML)
|
|
ATE553196T1
(de)
|
2007-02-27 |
2012-04-15 |
Rosetta Genomics Ltd |
Zusammensetzung und verfahren zur modulation von zellproliferation und zelltod
|
|
EP2126584B1
(en)
|
2007-03-16 |
2012-12-19 |
CovalX AG |
Direct mass spectrometric analysis of drug candidates targeting protein complexes
|
|
EP2134874A4
(en)
|
2007-04-10 |
2010-12-22 |
Univ Nat Taiwan |
PROGNOSIS OF SURVIVAL RATE OF PATIENTS AFTER TREATMENT WITH miRNA
|
|
JP5592251B2
(ja)
|
2007-04-30 |
2014-09-17 |
ジ・オハイオ・ステイト・ユニバーシティ・リサーチ・ファウンデイション |
膵臓癌を正常な膵臓機能および／または慢性膵炎と識別する方法
|
|
US20090005336A1
(en)
|
2007-05-08 |
2009-01-01 |
Zhiguo Wang |
Use of the microRNA miR-1 for the treatment, prevention, and diagnosis of cardiac conditions
|
|
US20090232893A1
(en)
|
2007-05-22 |
2009-09-17 |
Bader Andreas G |
miR-143 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
|
US20090131354A1
(en)
|
2007-05-22 |
2009-05-21 |
Bader Andreas G |
miR-126 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION
|
|
WO2008154098A2
(en)
|
2007-06-07 |
2008-12-18 |
Wisconsin Alumni Research Foundation |
Reagents and methods for mirna expression analysis and identification of cancer biomarkers
|
|
CA2690144A1
(en)
|
2007-06-08 |
2008-12-18 |
The Government Of The United States Of America As Represented By The Sec Retary Of Department Of Health And Human Services |
Methods for determining hepatocellular carcinoma subtype and detecting hepatic cancer stem cells
|
|
WO2008154333A2
(en)
|
2007-06-08 |
2008-12-18 |
Asuragen, Inc. |
Mir-34 regulated genes and pathways as targets for therapeutic intervention
|
|
US8053186B2
(en)
|
2007-06-15 |
2011-11-08 |
The Ohio State University Research Foundation |
Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing
|
|
ES2496172T3
(es)
|
2007-07-31 |
2014-09-18 |
The Ohio State University Research Foundation |
Métodos para invertir la metilación por selección dirigida de DNMT3A y DNMT3B
|
|
AU2008283997B2
(en)
|
2007-08-03 |
2014-04-10 |
The Ohio State University Research Foundation |
Ultraconserved regions encoding ncRNAs
|
|
CN101836112A
(zh)
|
2007-08-22 |
2010-09-15 |
俄亥俄州立大学研究基金会 |
用于在人急性白血病中诱导epha7和erk磷酸化的脱调节的方法和组合物
|
|
US20090061424A1
(en)
|
2007-08-30 |
2009-03-05 |
Sigma-Aldrich Company |
Universal ligation array for analyzing gene expression or genomic variations
|
|
WO2009033140A1
(en)
|
2007-09-06 |
2009-03-12 |
The Ohio State University Research Foundation |
Microrna signatures in human ovarian cancer
|
|
CA2702241A1
(en)
|
2007-10-11 |
2009-04-16 |
The Ohio State University Research Foundation |
Methods and compositions for the diagnosis and treatment of esophageal adenocarcinomas
|
|
CA2703707A1
(en)
|
2007-10-26 |
2009-04-30 |
The Ohio State University Research Foundation |
Methods for identifying fragile histidine triad (fhit) interaction and uses thereof
|
|
CA2705488C
(en)
|
2007-11-12 |
2018-01-16 |
Curtis C. Harris |
Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer
|
|
US20090123933A1
(en)
|
2007-11-12 |
2009-05-14 |
Wake Forest University Health Sciences |
Microrna biomarkers in lupus
|
|
US20100323357A1
(en)
|
2007-11-30 |
2010-12-23 |
The Ohio State University Research Foundation |
MicroRNA Expression Profiling and Targeting in Peripheral Blood in Lung Cancer
|
|
WO2009070805A2
(en)
|
2007-12-01 |
2009-06-04 |
Asuragen, Inc. |
Mir-124 regulated genes and pathways as targets for therapeutic intervention
|
|
WO2009086156A2
(en)
|
2007-12-21 |
2009-07-09 |
Asuragen, Inc. |
Mir-10 regulated genes and pathways as targets for therapeutic intervention
|
|
EP2604704B1
(en)
|
2008-02-01 |
2018-10-03 |
The General Hospital Corporation |
Use of microvesicles in diagnosis and prognosis of brain tumor
|
|
US20090263803A1
(en)
|
2008-02-08 |
2009-10-22 |
Sylvie Beaudenon |
Mirnas differentially expressed in lymph nodes from cancer patients
|
|
CA2717030A1
(en)
|
2008-02-28 |
2009-09-03 |
The Ohio State University Research Foundation |
Microrna signatures associated with cytogenetics and prognosis in acute myeloid leukemia (aml) and uses thereof
|
|
CA2716906A1
(en)
|
2008-02-28 |
2009-09-03 |
The Ohio State University Research Foundation |
Microrna-based methods and compositions for the diagnosis, prognosis and treatment of gastric cancer
|
|
WO2009108860A2
(en)
|
2008-02-28 |
2009-09-03 |
The Ohio University Rasearch Foundation |
Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders
|
|
US20110052502A1
(en)
|
2008-02-28 |
2011-03-03 |
The Ohio State University Research Foundation |
MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof
|
|
WO2009111643A2
(en)
|
2008-03-06 |
2009-09-11 |
Asuragen, Inc. |
Microrna markers for recurrence of colorectal cancer
|
|
WO2009154835A2
(en)
|
2008-03-26 |
2009-12-23 |
Asuragen, Inc. |
Compositions and methods related to mir-16 and therapy of prostate cancer
|
|
EP2285960B1
(en)
|
2008-05-08 |
2015-07-08 |
Asuragen, INC. |
Compositions and methods related to mir-184 modulation of neovascularization or angiogenesis
|
|
CN102112110A
(zh)
|
2008-06-06 |
2011-06-29 |
米尔纳医疗股份有限公司 |
用于RNAi试剂体内递送的新型组合物
|
|
AU2009257410B2
(en)
|
2008-06-11 |
2014-03-06 |
Fudan University |
Use of miR-26 family as a predictive marker of hepatocellular carcinoma and responsiveness to therapy
|
|
WO2010019694A1
(en)
|
2008-08-12 |
2010-02-18 |
The Ohio State University Research Foundation |
Micro-rna-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma
|
|
AU2009316584A1
(en)
|
2008-11-21 |
2010-05-27 |
The Ohio State University Research Foundation |
Tcl1 as a transcriptional regulator
|
|
US20110275534A1
(en)
|
2008-12-05 |
2011-11-10 |
The Ohio State University |
MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Ovarian Cancer Using a Real-Time PCR Platform
|
|
CA2753562A1
(en)
|
2009-02-26 |
2010-09-02 |
The Ohio State University Research Foundation |
Micrornas in never-smokers and related materials and methods
|